Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 49

    Pfizer-Lilly Non-Opioid Drug Tanezumab decreases Osteoarthritis Pain: Shows late-stage Study

    Pfizer-Lilly Non-Opioid Drug Tanezumab decreases Osteoarthritis Pain: Shows late-stage Study

    Medical Dialogues Bureau24 Oct 2018 4:44 PM IST
    New Delhi: A non-opioid drug developed by Pfizer and Eli Lilly met the main goals of a late-stage study, in which over half of the patients reported a...
    Unregulated sale of prescription medicines: PIL in HC against drug regulators

    Unregulated sale of prescription medicines: PIL in HC against drug regulators

    Medical Dialogues Bureau23 Oct 2018 6:07 PM IST
    New Delhi: A Public Interest Litigation (PIL) was filed in Bombay High court by Mumbai based lawyer Bharat Kothari against the Government of...
    USFDA not mandatory for Medical Devices: DOP releases Guideline for public procurement

    USFDA not mandatory for Medical Devices: DOP releases Guideline for public procurement

    Medical Dialogues Bureau22 Oct 2018 2:05 PM IST
    New Delhi: Giving relief to domestic medical device makers, the government has asked the procurement agencies to follow the Bureau of Indian Standards...
    True Properties of Vitamin E Overlooked: Merck Launches Book for Awareness

    True Properties of Vitamin E Overlooked: Merck Launches Book for Awareness

    Medical Dialogues Bureau21 Oct 2018 12:01 PM IST
    Mumbai: Merck Consumer Health India - a leader in Vitamin E in India - announced the publication of the country’s first handbook that highlights the...
    Dengue vaccine should be approved: European Medicines Agency

    Dengue vaccine should be approved: European Medicines Agency

    Medical Dialogues Bureau20 Oct 2018 3:03 PM IST
    LONDON - Europe's medicines regulator has recommended the approval of the first vaccine for dengue despite concerns about the vaccine's wide use and a...
    Trivitron launches 4 novel Newborn Screening panels, Check out details

    Trivitron launches 4 novel Newborn Screening panels, Check out details

    Medical Dialogues Bureau19 Oct 2018 1:21 PM IST
    Bratislava, Slovakia: Trivitron’s Labsystems Diagnostics Oy, a leading brand that develops and manufactures high quality diagnostic tests for clinical...
    Singh brothers, 8 other entities told to repay over Rs 403 crore to Fortis Healthcare: SEBI

    Singh brothers, 8 other entities told to repay over Rs 403 crore to Fortis Healthcare: SEBI

    Medical Dialogues Bureau18 Oct 2018 11:19 AM IST
    New Delhi: Finding alleged diversion of funds, markets regulator Sebi Wednesday directed former promoters of Fortis Healthcare Shivinder Mohan Singh,...
    Haryana: KARNAL to get Mega pharma park, says govt

    Haryana: KARNAL to get Mega pharma park, says govt

    Medical Dialogues Bureau17 Oct 2018 3:10 PM IST
    Chandigarh: The Haryana government Tuesday said a pharma park will be established over 100 acres of land in Karnal.Also, the state's Industries and...
    CCI Approves Acquisition of Star Health by Jhunjhunwala led Safecrop Holdings

    CCI Approves Acquisition of Star Health by Jhunjhunwala led Safecrop Holdings

    Medical Dialogues Bureau16 Oct 2018 1:57 PM IST
    New Delhi: The Completion Commission said Monday it has approved the acquisition of Star Health and Allied Insurance Company by Safecrop Holdings, a...
    Sun Pharma to Pump in Rs 200 Crore More in Assam Plant

    Sun Pharma to Pump in Rs 200 Crore More in Assam Plant

    Medical Dialogues Bureau15 Oct 2018 2:01 PM IST
    Guwahati: Assam government on Saturday said medicine firm Sun Pharma will invest an additional Rs 200 crore at its plant in the state to augment...
    Eli Lilly Launches Olumiant-once-daily oral therapy for rheumatoid arthritis In India

    Eli Lilly Launches Olumiant-once-daily oral therapy for rheumatoid arthritis In India

    Medical Dialogues Bureau14 Oct 2018 11:33 AM IST
    Rheumatoid Arthritis is a systemic autoimmune disease characterized by inflammation and progressive destruction of jointsNew Delhi: Drug firm Eli...
    Clinical Trial of Sirolimus balloon catheter: Cardiologist invests 60 million dollar in Device maker

    Clinical Trial of Sirolimus balloon catheter: Cardiologist invests 60 million dollar in Device maker

    Medical Dialogues Bureau13 Oct 2018 12:30 PM IST
    HOUSTON: An Indian-American cardiologist and entrepreneur has invested $60 million in a medical company that will support clinical trial on cardiac...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    300,000 doses of Mercks Ebola shot available for emergencies: GAVI Vaccine Alliance

    300,000 doses of Merck's Ebola shot available for emergencies: GAVI Vaccine Alliance

    German drug assessment body not convinced by Bayers cancer drug Vitrakvi

    German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok